newsfilter
← Latest News
GlobeNewswire·

Recro Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Underwriters' Full Exercise of Option Brings Gross Proceeds to $34.5 Million EXTON, Pa., May 14, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving comp